30
weeks for ablative fractional laser resurfacing (according to treatment
severity) prior to treatment, except special recommendations.
▪ Use of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-
containing agents) one week before and after each treatment session,
as per the practitioner’s discretion.
▪ Application of the device near the thorax may increase risk of cardiac
fibrillation.
▪ Avoid application of device over the head, eyes, across the mouth and
front of neck.
▪ As per the practitioner's discretion, refrain from treating any condition
which might make it unsafe for the patient.
6.3 Precautions
▪ Safety of powered muscle stimulators for use during pregnancy has not
been established.
▪ Caution should be used for patients with suspected or diagnosed heart
problems.
▪ Caution should be used for patients with suspected or diagnosed
epilepsy.
▪ Caution should be used in the presence of the following: a. When there
is a tendency to hemorrhage following acute trauma or fracture; b.
Following recent surgical procedures when muscle contraction may
disrupt the healing process; c. Over the menstruating or pregnant
uterus; and d. Over areas of the skin lacking normal sensation.
▪ Some patients may experience skin irritation or hypersensitivity due to
the electrical stimulation or electric conductive medium. The irritation
can usually be reduced by using an alternate conductive medium, or
alternate electrode placement.
▪ Electrode placement and stimulation settings should be based on the
guidance of the prescribing practitioner.
▪ Powered muscle stimulators should be kept out of the reach of
children.
▪ Powered muscle stimulators should be used only with the leads and
electrodes recommended for use by the manufacturer
To Next Page
Loading...
